Lobbying

Savara SVRA's latest lobbying report covers Q2 2026, at $60K. The four quarters Q4 2025–Q3 2026 total $150K. Its first report covers Q4 2025; the issues it reports most are Pharmacy and Health Issues.

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$150K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2025
The first quarter a report named it

Lobbying by quarter

Savara lobbying by quarter
Savara lobbying by quarter
QuarterAmountReports
Q4 2025$30K1
Q1 2026$60K1
Q2 2026$60K1
Q3 2026$00

By issue

  • Pharmacy$75K · 3 reports
  • Health issues$60K · 2 reports
  • Medicare and Medicaid$15K · 1 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Executive Office of the President (EOP)2 reports
  • Health & Human Services, Dept of (HHS)2 reports
  • HOUSE OF REPRESENTATIVES2 reports
  • SENATE2 reports

Firms it paid

Firm
LMH Strategic Solutions$150K3 quarters

Former officials lobbying for it

Former position
ALANNA TEMMELegislative Director, U.S. Representative Jon PorterQ2 2026
SOPHIE KHANAHMADILegislative Asst., Rep. Martha Roby; Legislative Asst., Rep. Lee Terry; Staff Asst./LC, Senator Jeff SessionsQ2 2026

Lobbying reports

Filed by
07/05for Q2LMH Strategic Solutions$60K
04/17for Q1LMH Strategic Solutions$60K
01/12for Q4 2025LMH Strategic Solutions$30K
01/11for Q4 2025LMH Strategic SolutionsUnder $5,000